{
    "nodes": [
        {
            "id": 0,
            "value": 2,
            "name": "AVE8062|AVE8062A",
            "group": 10
        },
        {
            "id": 1,
            "value": 1,
            "name": "combretastatin",
            "group": 10
        },
        {
            "id": 2,
            "value": 1,
            "name": "vascular",
            "group": 3
        },
        {
            "id": 3,
            "value": 1,
            "name": "disrupting",
            "group": 5
        },
        {
            "id": 4,
            "value": 1,
            "name": "Angiogenesis",
            "group": 4
        },
        {
            "id": 5,
            "value": 1,
            "name": "has an essential role",
            "group": 6
        },
        {
            "id": 6,
            "value": 1,
            "name": "promoting",
            "group": 13
        },
        {
            "id": 7,
            "value": 1,
            "name": "supporting",
            "group": 13
        },
        {
            "id": 8,
            "value": 1,
            "name": "tumor",
            "group": 2
        },
        {
            "id": 9,
            "value": 1,
            "name": "growth",
            "group": 1
        },
        {
            "id": 10,
            "value": 1,
            "name": "tumor vascular network",
            "group": 3
        },
        {
            "id": 11,
            "value": 1,
            "name": "angiogenic",
            "group": 4
        },
        {
            "id": 12,
            "value": 1,
            "name": "interaction",
            "group": 8
        },
        {
            "id": 13,
            "value": 1,
            "name": "endothelial cells",
            "group": 11
        },
        {
            "id": 14,
            "value": 1,
            "name": "extracellular matrix",
            "group": 7
        },
        {
            "id": 15,
            "value": 1,
            "name": "angiogenic",
            "group": 4
        },
        {
            "id": 16,
            "value": 1,
            "name": "improve",
            "group": 13
        },
        {
            "id": 17,
            "value": 1,
            "name": "tumor",
            "group": 2
        },
        {
            "id": 18,
            "value": 1,
            "name": "control",
            "group": 6
        },
        {
            "id": 19,
            "value": 2,
            "name": "vascular-targeting agents|vascular-disrupting agents",
            "group": 10
        },
        {
            "id": 20,
            "value": 2,
            "name": "VTA|VDAs",
            "group": 10
        },
        {
            "id": 21,
            "value": 2,
            "name": "VTAs|VTAs",
            "group": 10
        },
        {
            "id": 22,
            "value": 1,
            "name": "antiangiogenic agents",
            "group": 10
        },
        {
            "id": 23,
            "value": 1,
            "name": "angiogenic",
            "group": 4
        },
        {
            "id": 24,
            "value": 1,
            "name": "angiogenic",
            "group": 4
        },
        {
            "id": 25,
            "value": 1,
            "name": "tumor masses",
            "group": 2
        },
        {
            "id": 26,
            "value": 1,
            "name": "tumor periphery",
            "group": 0
        },
        {
            "id": 27,
            "value": 1,
            "name": "VEGF receptor",
            "group": 15
        },
        {
            "id": 28,
            "value": 2,
            "name": "VDAs|VDAs",
            "group": 10
        },
        {
            "id": 29,
            "value": 1,
            "name": "target",
            "group": 6
        },
        {
            "id": 30,
            "value": 1,
            "name": "destroy",
            "group": 14
        },
        {
            "id": 31,
            "value": 1,
            "name": "established",
            "group": 12
        },
        {
            "id": 32,
            "value": 1,
            "name": "tumor vessels",
            "group": 3
        },
        {
            "id": 33,
            "value": 1,
            "name": "destruction",
            "group": 5
        },
        {
            "id": 34,
            "value": 1,
            "name": "masses",
            "group": 2
        },
        {
            "id": 35,
            "value": 1,
            "name": "necrosis",
            "group": 9
        },
        {
            "id": 36,
            "value": 1,
            "name": "survival",
            "group": 9
        },
        {
            "id": 37,
            "value": 1,
            "name": "peripheral tumor layer",
            "group": 2
        },
        {
            "id": 38,
            "value": 1,
            "name": "small-molecule VDAs",
            "group": 10
        },
        {
            "id": 39,
            "value": 1,
            "name": "flavonoids",
            "group": 10
        },
        {
            "id": 40,
            "value": 1,
            "name": "5,6-dimethylxanthenone-4-acetic acid",
            "group": 10
        },
        {
            "id": 41,
            "value": 1,
            "name": "DMXAA",
            "group": 10
        },
        {
            "id": 42,
            "value": 1,
            "name": "microtubule-destabilizing agents",
            "group": 10
        },
        {
            "id": 43,
            "value": 1,
            "name": "antitubulin agents",
            "group": 10
        },
        {
            "id": 44,
            "value": 1,
            "name": "combretastatin A4-phosphate derivative",
            "group": 10
        }
    ],
    "links": [
        {
            "source": 7,
            "target": 9,
            "value": 2
        },
        {
            "source": 6,
            "target": 9,
            "value": 2
        },
        {
            "source": 9,
            "target": 8,
            "value": 2
        },
        {
            "source": 12,
            "target": 13,
            "value": 2
        },
        {
            "source": 12,
            "target": 14,
            "value": 2
        },
        {
            "source": 18,
            "target": 17,
            "value": 2
        },
        {
            "source": 29,
            "target": 32,
            "value": 2
        },
        {
            "source": 29,
            "target": 28,
            "value": 2
        },
        {
            "source": 30,
            "target": 32,
            "value": 2
        },
        {
            "source": 30,
            "target": 28,
            "value": 2
        },
        {
            "source": 33,
            "target": 34,
            "value": 2
        },
        {
            "source": 3,
            "target": 2,
            "value": 2
        },
        {
            "source": 5,
            "target": 4,
            "value": 2
        },
        {
            "source": 5,
            "target": 6,
            "value": 2
        },
        {
            "source": 5,
            "target": 4,
            "value": 2
        },
        {
            "source": 5,
            "target": 7,
            "value": 2
        },
        {
            "source": 16,
            "target": 19,
            "value": 2
        },
        {
            "source": 16,
            "target": 18,
            "value": 2
        },
        {
            "source": 31,
            "target": 32,
            "value": 2
        },
        {
            "source": 36,
            "target": 37,
            "value": 2
        },
        {
            "source": 35,
            "target": 34,
            "value": 2
        }
    ]
}